Works matching IS 18607179 AND DT 2022 AND VI 17 AND IP 4

Results: 16

Front Cover: Rational Design and Identification of Harmine‐Inspired, N‐Heterocyclic DYRK1A Inhibitors Employing a Functional Genomic In Vivo Drosophila Model System (ChemMedChem 4/2022).

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202200066

By:

Huizar, Francisco J.;
Hill, Harrison M.;
Bacher, Emily P.;
Eckert, Kaitlyn E.;
Gulotty, Eva M.;
Rodriguez, Kevin X.;
Tucker, Zachary D.;
Banerjee, Monimoy;
Liu, Haining;
Wiest, Olaf;
Zartman, Jeremiah;
Ashfeld, Brandon L.

Publication type:

Article

Cover Feature: Calcification‐Based Cancer Diagnosis and Therapy (ChemMedChem 4/2022).

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202200065

By:

Shou, Hao;
Wu, Jicheng;
Tang, Ning;
Wang, Ben

Publication type:

Article

Medicinal Chemistry for Practitioners. Edited by Jie Jack Li.

Published in:: ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100752
Publication type:: Article

Synthesis of Bitopic Ligands as Potent Dopamine D<sub>2</sub> Receptor Agonists.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100681

By:

Qian, Mingcheng;
Zhou, Kuo;
Wu, Yi;
Luo, Zhijie;
Xiao, Zhekai;
Sun, Jingjing;
Zeng, Siyu;
Yao, Yi;
Zhao, Shuai;
Chen, Xin

Publication type:

Article

<sup>19</sup>F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100701

By:

Li, Yanan;
Cui, Jing;
Li, Chenlong;
Zhou, Huimin;
Chang, Jun;
Aras, Omer;
An, Feifei

Publication type:

Article

Convenient Synthesis of Alternatively Bridged Tryptophan Ketopiperazines and Their Activities against Trypanosomatid Parasites.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100664

By:

Cockram, Peter E.;
Turner, Callum A.;
Slawin, Alexandra M. Z.;
Smith, Terry K.

Publication type:

Article

Mitochondria‐Targeted Triphenylphosphonium Conjugated C‐3 Modified Betulin: Synthesis, Antitumor Properties and Mechanism of Action.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100659

By:

Xu, Geng;
Xu, Xiaojia;
Liu, Jiansong;
Jia, Qi;
Ke, Changhong;
Zhang, Hanyuan;
Xu, Chao;
Ou, E;
Tan, Wen;
Zhao, Yu

Publication type:

Article

Movement of Mitochondria with Mutant DNA through Extracellular Vesicles Helps Cancer Cells Acquire Chemoresistance.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100642

By:

Abad, Etna;
Lyakhovich, Alex

Publication type:

Article

Evaluation of the Correlation between Porphyrin Accumulation in Cancer Cells and Functional Porphyrin Positions of the Phenyl Group.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100636

By:

Tojo, Toshifumi;
Niiuchi, Ayano;
Kondo, Takeshi;
Yuasa, Makoto

Publication type:

Article

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100582

By:

Thun‐Hohenstein, Siegfried T. D.;
Suits, Timothy F.;
Malla, Tika R.;
Tumber, Anthony;
Brewitz, Lennart;
Choudhry, Hani;
Salah, Eidarus;
Schofield, Christopher J.

Publication type:

Article

Synthesis of Fluorinated Imidazole[4,5f][1,10]phenanthroline Derivatives as Potential Inhibitors of Liver Cancer Cell Proliferation by Inducing Apoptosis via DNA Damage.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100537

By:

Bai, Ming‐Jun;
Liu, Ning‐Zhi;
Zhou, Yu‐Ling;
Liu, Jie;
Zou, Jun;
Tan, Wei‐Jun;
Huang, Xiao‐Ting;
Mei, Wen‐Jie

Publication type:

Article

Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100520

By:

Balsa, Lucia M.;
Rodriguez, Maria R.;
Parajón‐Costa, Beatriz S.;
González‐Baró, Ana C.;
Lavecchia, Martin J.;
León, Ignacio E.

Publication type:

Article

The Discovery of Potential MDM2 Inhibitors: A Combination of Pharmacophore Modeling, Virtual Screening, Molecular Docking Studies, and in vitro/in vivo Biological Evaluation.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100517

By:

Zhang, Xuelin;
Zhou, Chunqiao;
Yang, Yang;
Liu, Hailin;
Wang, Song;
Ding, Xiaoli;
Wang, Hu

Publication type:

Article

Rational Design and Identification of Harmine‐Inspired, N‐Heterocyclic DYRK1A Inhibitors Employing a Functional Genomic In Vivo Drosophila Model System**.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100512

By:

Huizar, Francisco J.;
Hill, Harrison M.;
Bacher, Emily P.;
Eckert, Kaitlyn E.;
Gulotty, Eva M.;
Rodriguez, Kevin X.;
Tucker, Zachary D.;
Banerjee, Monimoy;
Liu, Haining;
Wiest, Olaf;
Zartman, Jeremiah;
Ashfeld, Brandon L.

Publication type:

Article

Synthesis and Evaluation of Antioxidant, Anti‐Edematogenic and Antinociceptive Properties of Selenium‐Sulfa Compounds.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100507

By:

Sacramento, Manoela;
Reis, Angélica S.;
Martins, Carolina C.;
Luchese, Cristiane;
Wilhelm, Ethel A.;
Alves, Diego

Publication type:

Article

Calcification‐Based Cancer Diagnosis and Therapy.

Published in:

ChemMedChem, 2022, v. 17, n. 4, p. 1, doi. 10.1002/cmdc.202100339

By:

Shou, Hao;
Wu, Jicheng;
Tang, Ning;
Wang, Ben

Publication type:

Article